Corrigendum to “Apremilast prevent doxorubicin-induced apoptosis and inflammation in heart through inhibition of oxidative stress mediated activation of NF-κB signaling pathways” (Pharmacological Reports (2018) 70(5) (993–1000), (S1734114017306679), (10.1016/j.pharep.2018.03.009))

  • Faisal Imam
  • , Naif O. Al-Harbi
  • , Mohammad Matar Al-Harbi
  • , Mushtaq Ahmad Ansari
  • , Abdullah F. Al-Asmari
  • , Mohd Nazam Ansari
  • , Wael A. Al-Anazi
  • , Saleh Bahashwan
  • , Mashal M. Almutairi
  • , Musaad Alshammari
  • , Mohammad Rashid Khan
  • , Abdulaziz Mohammed Alsaad
  • , Moureq Rashed Alotaibi

Research output: Contribution to journal › Comment/debate

Fingerprint

Dive into the research topics of 'Corrigendum to “Apremilast prevent doxorubicin-induced apoptosis and inflammation in heart through inhibition of oxidative stress mediated activation of NF-κB signaling pathways” (Pharmacological Reports (2018) 70(5) (993–1000), (S1734114017306679), (10.1016/j.pharep.2018.03.009))'. Together they form a unique fingerprint.

Medicine and Dentistry

Nursing and Health Professions